---
Dermatologic Therapy,Volume 31, Issue 1, January/February 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 8, 2018 Category: Dermatology Source Type: research
Issue Information
(Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 8, 2018 Category: Dermatology Tags: Issue Information Source Type: research
Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis)
Dermatologic Therapy,Volume 31, Issue 3, May/June 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Authors: D.Rigopoulos
,
D.Ioannides
,
G.Chaidemenos
,
P.Kallidis
,
A.Voultsidou
,
A.Matekovits
,
E.Soura Source Type: research
Bacillus Calmette ‐Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus
Dermatologic Therapy,Volume 31, Issue 3, May/June 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Authors: Mohamad M.Nasr
,
Howyda M.Ebrahim
,
Fathia M.Khattab
,
Ayman M.Marei Source Type: research
Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis)
Dermatologic Therapy, EarlyView. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Source Type: research
Bacillus Calmette ‐Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus
Dermatologic Therapy, EarlyView. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Source Type: research
---
Dermatologic Therapy, Ahead of Print. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Source Type: research
Bacillus Calmette ‐Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus
Abstract
The aim of this study was to evaluate the safety and efficacy of Bacillus Calmette‐Guerin, polysaccharide nucleic acid (BCG‐PSN) therapy in the treatment of oral and cutaneous LP. Twenty‐four LP patients were included in this study and classified randomly into; Oral LP group (OLP), 11 patients and Cutaneous LP group (CLP), 13 patients. All patients received intradermal injections of BCG‐PSN, twice weekly for three weeks. Patients with complete response were followed up for 3 months. The assessment in OLP was based on the reduction in the treated area, (Reticulation/Erythema/Ulceration) REU scoring system a...
Source: Dermatologic Therapy - February 6, 2018 Category: Dermatology Authors: Mohamad M. Nasr, Howyda M. Ebrahim, Fathia M. Khattab, Ayman M. Marei Tags: THERAPEUTIC HOTLINE: SHORT PAPERS Source Type: research
Clinical evaluation of a novel fractional radiofrequency device for hair growth: Fractional radiofrequency for hair growth stimulation
Dermatologic Therapy,Volume 31, Issue 3, May/June 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Authors: InesVerner
,
TorelloLotti Source Type: research
Clinical evaluation of a novel fractional radiofrequency device for hair growth: Fractional radiofrequency for hair growth stimulation
Dermatologic Therapy, EarlyView. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Source Type: research
Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents
Dermatologic Therapy,Volume 31, Issue 1, January/February 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Source Type: research
---
Dermatologic Therapy, Ahead of Print. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Source Type: research
---
Dermatologic Therapy,Volume 31, Issue 1, January/February 2018. (Source: Dermatologic Therapy)
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Source Type: research
Clinical evaluation of a novel fractional radiofrequency device for hair growth: Fractional radiofrequency for hair growth stimulation
Abstract
AGA is a common disorder. Different treatments are available to prevent hair loss and achieve hair growth with variable results. The purpose of the present study was to evaluate the efficacy and safety of a novel fractional radiofrequency (RF) device (HairLux, Innogen Technologies Ltd., Yokneam, Israel), to prevent hair loss and induce hair growth. Twenty‐five patients received 10 fractional RF treatments every 2 weeks, and were followed up 2 months after the last treatment. All patients were evaluated by global photography. In 10 patients, blinded manual hair counts were performed. Patients demonstrated less ha...
Source: Dermatologic Therapy - January 15, 2018 Category: Dermatology Authors: Ines Verner, Torello Lotti Tags: THERAPEUTIC HOTLINE: SHORT PAPERS Source Type: research
